AllianceBernstein
AGN

AllianceBernstein’s Allergan Inc AGN Stock Holding History

AllianceBernstein’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,661,751
Closed -$566M – 3620
2014
Q4 		$566M Sell
2,661,751
-937,127
-26% -$186M 0.47% 45
2014
Q3 		$641M Sell
3,598,878
-15,371
-0.4% -$2.55M 0.54% 31
2014
Q2 		$612M Sell
3,614,249
-1,777,588
-33% -$277M 0.52% 32
2014
Q1 		$669M Buy
5,391,837
+719,705
+15% +$87.6M 0.58% 27
2013
Q4 		$519M Buy
4,672,132
+243,217
+5% +$23.2M 0.46% 46
2013
Q3 		$401M Sell
4,428,915
-170,884
-4% -$15.3M 0.4% 59
2013
Q2 		$387M Buy
+4,599,799
New +$477M 0.41% 56

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

AllianceBernstein's AGN Position: Q1 2015 in Review

AllianceBernstein sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,661,751 shares — an estimated $566M sold.

AllianceBernstein first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $669M in Q1 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • AllianceBernstein reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • AllianceBernstein sold 2,661,751 Allergan Inc shares in Q1 2015, an estimated $566M.
  • AllianceBernstein first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • AllianceBernstein's Allergan Inc position peaked at $669M in Q1 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on AllianceBernstein's 13F filing for Q1 2015, filed 13 May 2015.